Altered expression or activity of CYP2C9 can be associated with various disease states. For example, reduced CYP2C9 activity has been linked to increased risk of adverse drug reactions and drug-induced liver injury. Conversely, overexpression of CYP2C9 in certain cancers may contribute to drug resistance, complicating treatment regimens.
